Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma

Changing epidemiology of hepatocellular carcinoma in Asia

(2022) Chen‐hao Zhang et al.   LIVER INTERNATIONAL

SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52

(2022) Yuchao Diao et al.   Cell Death & Disease

Hepatocellular carcinoma

(2022) Arndt Vogel et al.   LANCET

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Emerging roles of spliceosome in cancer and immunity

(2021) Hui Yang et al.   Protein & Cell

Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma

(2020) Joseph C Ahn et al.   HEPATOLOGY

SF3B4 Plays an Oncogenic Role in Esophageal Squamous Cell Carcinoma

(2020) SHINYA KIDOGAMI et al.   ANTICANCER RESEARCH

SRSF3 Depletion Leads to an Increase in SF3B4 Expression in SNU-368 HCC Cells

(2020) JEEHAN LEE et al.   ANTICANCER RESEARCH

A twenty gene-based gene set variation score reflects the pathological progression from cirrhosis to hepatocellular carcinoma

(2019) Yan Lin et al.   Aging-US

Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

(2018) Jorge A. Marrero et al.   HEPATOLOGY

Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma

(2018) Qingyu Shen et al.   HEPATOLOGY

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2018) Peter R. Galle et al.   JOURNAL OF HEPATOLOGY

Trichostatin a Protects Dendritic Cells Against Oxygen-Glucose Deprivation via the SRSF3/PKM2/Glycolytic Pathway

(2018) Hongyun Jiang et al.   Frontiers in Pharmacology

Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation

(2018) John B. Kisiel et al.   HEPATOLOGY

SF3B4 is regulated by microRNA-133b and promotes cell proliferation and metastasis in hepatocellular carcinoma

(2018) Zhiyong Liu et al.   EBioMedicine

SF3B4 is decreased in pancreatic cancer and inhibits the growth and migration of cancer cells

(2017) Wentao Zhou et al.   TUMOR BIOLOGY

A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases

(2014) Helena Janols et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer

(2013) J. Yu et al.   JOURNAL OF IMMUNOLOGY

Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma

(2012) Florie Borel et al.   JOURNAL OF HEPATOLOGY

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis

(2009) A. SINGAL et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS